Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Cars.com
CARS
5
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
US OptionsDetailed Quotes
APLS250417C18000
- 0.00
- 0.000.00%
15min DelayClose Apr 4 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest18.00Strike Price0.00Turnover66.60%IV-9.86%PremiumApr 17, 2025Expiry Date1.97Intrinsic Value100Multiplier11DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.8363Delta0.1085Gamma9.08Leverage Ratio-0.0281Theta0.0042Rho7.59Eff Leverage0.0084Vega
Apellis Pharmaceuticals Newsroom
RBC Capital Initiates Apellis Pharmaceuticals(APLS.US) With Hold Rating, Announces Target Price $24
Mizuho Securities Maintains Apellis Pharmaceuticals(APLS.US) With Hold Rating, Maintains Target Price $30
Scotiabank Maintains Sector Perform on Apellis Pharmaceuticals, Raises Price Target to $31
Apellis Pharmaceuticals Analyst Ratings
Mizuho Securities Maintains Apellis Pharmaceuticals(APLS.US) With Hold Rating, Maintains Target Price $30
Scotiabank Maintains Apellis Pharmaceuticals(APLS.US) With Hold Rating, Raises Target Price to $31
Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Apellis Pharmaceuticals (APLS)
William Blair Maintains Apellis Pharmaceuticals(APLS.US) With Buy Rating
Morgan Stanley Maintains Apellis Pharmaceuticals(APLS.US) With Hold Rating, Maintains Target Price $30
Cautious Hold on Apellis Pharmaceuticals Amid Competitive Landscape and Promising Empaveli Prospects
Jefferies Maintains Apellis Pharmaceuticals(APLS.US) With Buy Rating, Maintains Target Price $57
Scotiabank Maintains Apellis Pharmaceuticals(APLS.US) With Hold Rating, Maintains Target Price $30
William Blair Maintains Apellis Pharmaceuticals(APLS.US) With Buy Rating
Buy Rating for Apellis Pharmaceuticals Driven by Empaveli's Market Potential and Efficacy in C3G Treatment
J.P. Morgan Maintains Apellis Pharmaceuticals(APLS.US) With Buy Rating, Cuts Target Price to $45
Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), CervoMed (CRVO) and Apellis Pharmaceuticals (APLS)
Mizuho Securities Maintains Apellis Pharmaceuticals(APLS.US) With Hold Rating, Announces Target Price $30
Apellis Pharmaceuticals (APLS) Gets a Hold From Mizuho Securities
UBS Maintains Apellis Pharmaceuticals(APLS.US) With Buy Rating, Cuts Target Price to $43
A Quick Look at Today's Ratings for Apellis Pharmaceuticals(APLS.US), With a Forecast Between $29 to $75
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call